The current valuation score of CorMedix Inc is 8.22, ranking 65 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 3.10, which is 1930.93% below the recent high of 62.87 and 1456.69% above the recent low of -41.99.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.